Eledon Pharmaceuticals, Inc. ( (ELDN) ) has released its Q3 earnings. Here is a breakdown of the information Eledon Pharmaceuticals, Inc.

A recent study published in Progress in Neuropsychopharmacology & Biological Psychiatry suggests that cannabidiol (commonly ...

Conifers are foundational to ecosystems globally, providing critical environmental and economic value. Yet, their long life ...

Professor Nancy Ip discusses her groundbreaking neuroscience research, focusing on neurotrophic factors and innovative ...

As a reminder, our cost structure is highly flexible and over 70% of our cost of sales are third-party costs, which are ...

These metasurfaces can support surface waves with momentum bandgaps that lead to amplification. By time-modulating the ...

A research team from the University of Basel has succeeded in synthesizing simple, environmentally sensitive cells complete ...

A research team has succeeded in synthesizing simple, environmentally sensitive cells complete with artificial organelles. For the first time, the researchers have also been able to emulate natural ...

TD Cowen analyst Yaron Werber has maintained their bullish stance on IOBT stock, giving a Buy rating yesterday. Yaron Werber has given his Buy ...

Creator Hwang Dong-hyuk opens up about this season’s new games, new cast and his dystopic vision that now feels frighteningly ...

"The publication of our phase 1/1b clinical data in healthy human subjects and patients with celiac disease, in such a prestigious peer reviewed journal, confirms that IMU-856's novel mechanism ...